Professional Documents
Culture Documents
25-Diabete - Paccosi 2020
25-Diabete - Paccosi 2020
Diabetes Research
and Clinical Practice
journal homepage: www.elsevier.com/locat e/dia bre s
Sara Paccosi a, Laura Pala b, Barbara Cresci b, Angela Silvano a, Marta Cecchi a,
Roberto Caporale c, Carlo Maria Rotella d, Astrid Parenti a,*
a
Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy
b
Diabetology, Careggi University Hospital, Florence, Italy
c
Cytofluorimetry and Immunotherapy Diagnostic Center, Careggi University Hospital, Florence, Italy
d
Department of Biomedical Clinical and Experimental Sciences, Endocrine Unit, University of Florence, Florence, Italy
A R T I C L E I N F O A B S T R A C T
Article history: Aim: Cardiovascular disease (CVD) is prevalent in women after menopause, which may be
Received 6 March 2020 associated with obesity, insulin resistance and metaflammation. Despite the recognized
Received in revised form role of immunological mechanisms in vascular remodeling, the role of dendritic cells
10 September 2020 (DCs) is still unclear. The aim was to characterize monocyte-derived DCs (Mo-DC) in
Accepted 26 October 2020 post-menopausal patients with type 2 diabetes (T2DM) and obese woman, without clinical
Available online 4 November 2020 manifestations of atherosclerosis.
Methods: Obese post-menopausal women with or without T2DM were enrolled and were
compared to age-matched healthy women. DCs obtained from patients were phenotypi-
Keywords:
cally and functionally characterized by flow cytometry and mixed lymphocyte reaction.
Dendritic cells
MRNA integrins expression was assessed by real time RT-PCR; circulating fetuin-A and adi-
Type 2 diabetes
ponectin levels were measured by ELISA.
Obesity
Results: Phenotypic dysregulation of Mo-DC reported was related to a defective allogenic
Menopause women
lymphocyte stimulation and to an increased mRNA of CD11c, CD18 and DC-SIGN/CD209
Cardiovascular disease
which regulate their adhesion to vascular wall cells. Fetuin-A and adiponectin levels were
Metaflammation
significantly altered and negatively correlated. Hyperglycaemia significantly impaired
CD14+ transdifferentiation into Mo-DC.
Conclusions: These data show a dysfunction of Mo-DCs obtained from precursors isolated
from T2DM obese post-menopausal woman without any documented clinical CV event.
Association of obesity to diabetes seems to worsen DC’s phenotype and function and
increase vascular inflammation.
Ó 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
* Corresponding author at: Department of of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence,
Viale Pieraccini 6-50139, Florence, Italy.
E-mail address: astrid.parenti@unifi.it (A. Parenti).
https://doi.org/10.1016/j.diabres.2020.108528
0168-8227/Ó 2020 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
2 diabetes research and clinical practice 170 (2020) 108528
Abbreviations
Table 1 – Clinical characteristics of enrolled patients. Mean ± SD or median ± range. *P < 0.05, , ***P < 0.001 vs obese. ^P < 0.001
vs T2DM. °P < 0.01, °°P < 0.001 vs T2DM and obese.
Age (years) 65,40 ± 8,23 64,36 ± 8,23 69,20 ± 7,70 65,94 ± 9,25
BMI (Kg/m2) 24,20 ± 4,50 37,54 ± 6,81 26,33 ± 3,49*** ° 33,52 ± 4,02
Total cholesterol (mg/dL) 160,00±20,00 219,22 ± 35,72 186,95 ± 32,00 176,18 ± 26,37*
HbA1c (%) 4,60 ± 0,80 5,63 ± 0,19^°° 7,56 ± 0,66 7,24 ± 0,56
HDL-C (mg/dL) 50,00± 15,01 61,22 ± 14,94 58,60 ± 10,61 54,53 ± 12,66
LDL-c (mg/dL) 95,20 ± 15,00 135,97 ± 35,98 107,84 ± 33,07 91,95 ± 25,51***
Glycemia (mg/dL) 90,10 ± 5,00 103 [62–128] 186 [104–240]* 123 [89–242]*
Triglycerides (mg/dL) 84,00 ± 10,00 108 [77–181] 81 [69–171] 141 [75–223]
7-amino-actinomycin D (7-AAD; Sigma-Aldrich, St Louis, Mo, amplification of 18 s rRNA was used as the normalizer. Real-
Usa, San Diego, CA) was used to exclude dead cells from anal- time PCR assays were performed using the Rotorgene RG-
ysis. For lymphocyte proliferation assay the following mono- 3000A cycle system (Qiagen, Germany). PCR amplification of
clonal antibodies were used: anti-CD3- PerCP-Cy 5.5, CD4-PE 18 s rRNA was used as the normalizer fw:
and -CD8-APC. After selection of CD3+CD4+ or CD3+CD8+ sub- ATTAAGGGTGTGGGCCGAAG and rev: GGTGATCACACGTTC-
sets, the shift of CFSE-FITC stained proliferating cells versus CACCT. The cycle was set at 95 °C for 5 s followed by 30 s at
the unstimulated lymphocytes was compared 60 °C and repeated 40 times.
RNA was isolated from Mo-DC obtained from patients with 3.1. Functional characterization of Mo-DCs of obese and
TRI Reagent (Sigma–Aldrich, Milan, Italy) and quantified T2DM patients
spectroscopically with NanoDrop (Thermo-fisher scientific,
Waltham, Massachusetts, USA). One lg of RNA was retro- We previously demonstrated that DC precursors isolated form
transcribed using Prime Script RT reagent Kit with gDNA T2DM obese patients displayed less capability to trans-
eraser (Takara, Otsu, Japan) and 50 ng of cDNA were amplified differentiate into mature monocyte-derived DCs (Mo-DCs).
with specific primers described below. For CD11c mRNA fw: To confirm their phenotype, their ability to stimulate allo-
CCAGTGTGGCTACAGCACTGGTGCC and rev: TGGGTGAGC- genic lymphocytes was assessed. Mo-DCs obtained from
TGGGTGGGGCCC; CD18 fw: CTGTCTGAGGACTCCAG- T2DM obese patients were significantly less able to induce
CAATGTGG and rev: CACCTGGAAGGTGATCGGGACATTGAT; cytotoxic lymphocytes CD8+ proliferation, compared to
DC-SIGN (CD209) fw: CCAGCAGATACATGGCCACAAGAGC and control- and obese-derived Mo-DCs, in accord to phenotypic
rev: CTGCAGCTTTAAGCTGGGTCAGGTTCT; PCR amplification analysis [14]. A defective function, although not statistically
was carried out as using SYBR Premix Ex Taq (Takara, Otsu, significant, was observed for Mo-DC obtained from T2DM-
Japan) according to manufacturer instructions on Rotorgene not obese patients. Moreover, no differences were observed
RG-3000A cycle system (Qiagen, Germany) platform.. PCR for CD4+ proliferation (Fig. 1).
4 diabetes research and clinical practice 170 (2020) 108528
Obese and T2DM patients are characterized by low-grade Fig. 2 – Real-time PCR for CD11c, CD18 and DC-SIGN/CD209
inflammation with increased adhesion molecule at vascular mRNA expression. Total RNA was isolated from Mo-DCs of
levels which mediate leucocyte recruitment. It was demon- obese, T2DM, and T2DM + obese patients and control
strated that Mo-DCs isolated from T2DM obese patients dis- subjects. Data are expressed as relative expression vs
played higher ability to adhere to human coronary vascular control healthy subjects (C). Means ± SEM, n = 8; *P < 0.05,
smooth muscle cells (CASMC) [14]. Consistently, Mo-DCs iso- **P < 0.01 vs control healthy subjects (C). ^P < 0.05 vs obese;
lated from healthy subjects significantly increased their adhe- #P < 0.05 vs T2DM.
sion to CASMC treated with IFNɣ and TNFa, compared to
control-untreated CASMC [15]. We then investigated mRNA
expression of counter-receptors of vascular adhesion mole-
cules, in Mo-DCs obtained from enrolled patients. As reported alone, T2DM alone or control DCs, supporting the hypothesis
in Fig. 2, CD11c, CD18 and DC-SIGN/CD209 mRNA expression that low grade inflammation affects DC phenotype at vascu-
was significantly higher in T2DM obese patients than obese lar level.
diabetes research and clinical practice 170 (2020) 108528 5
3.3. Effect of high D-glucose on CD14+ trans- obese patients, but its role in the pathogenesis of diabetes
differentiation and iDC maturation and obesity is still discussed [16,17]. We then characterized
fetuin-A and adiponectin levels in enrolled patients. As
Since Mo-DCs obtained from T2DM obese patients display reported in Fig. 4A, adiponectin levels were significantly lower
defects on phenotype and function compared to obese and in T2DM obese patients compared to controls (p
control ones, we investigated the effect of high D-glucose value = 0.0083). Consistently, T2DM obese patients displayed
concentrations on CD14+ trans-differentiation into iDC and significant higher concentration of fetuin-A, compared to
then their maturation (Mo-DCs) in response to LPS. For this controls (p value = 0.0457, Fig. 4B). No differences were found
purpose, CD14+ isolated from healthy subjects were grown in fetuin-A when patients were divided into 2 subgroups,
in the presence of increasing concentration of D-glucose according to HbA1c: T2DM obese with HbA1c < 7.0 and
and let to obtain Mo-DCs. We used 33 mM mannitol as a T2DM obese with HbA1c > 7.0 (data not shown). A negative
high-osmolarity control treatment. Flow cytometry analysis correlation between fetuin-A and adiponectin was found in
showed that 33 mM D-glucose significantly impaired Mo- all population (r = -0.492p value = 0.00108, Fig. 4C), and in pop-
DCs yield, although did not affect CD14+ trans- ulation stratified according to the presence/absence of T2DM
differentiation into iDCs, demonstrated by a significant and obesity (Fig. 4D). A negative (r = -0.416p value = 0.0199)
decrease of cells expressing CD83 (Fig. 3A). This impairment and positive significant correlation (r = 0.549p value = 0.00139)
was not due to high osmolarity, since 33 mM mannitol was with BMI was obtained for adiponectin and fetuin-A, respec-
devoid of any effect. However, hyperglycaemia did not impair tively (Fig. 4E and F).
iDC maturation into Mo-DCs, when they were obtained from
CD14+ in normoglycaemic conditions and then were let to 4. Discussion
maturate into Mo-DCs in the presence of 33 mM D-glucose
(Fig. 3B). T2DM is as a chronic, low-grade inflammatory disease caused
by long-term immune system imbalance, and is often associ-
3.4. Fetuin-A and adiponectin expression ated with obesity or MetS. Increasing evidences support the
role of autoimmunity and adaptive immune system in the
Fetuin-A is a multifunctional plasma protein associated with pathogenesis of T2DM and its vascular complications [18].
insulin resistance. Its plasma levels are higher in T2DM or The impact of DCs on the initiation and progression of
Fig. 3 – Effect of high D-glucose on CD14+ trans-differentiation (A) and iDC maturation (B) into Mo-DCs. (A) Mo-DCs were
obtained from CD14+ grown for 7 days in the presence of increasing D-glucose concentrations. (B) iDC obtained from CD14+
grown in standard medium were then let to maturate into Mo-DCs in the presence of 33 mM D-glucose for 24 h. Means ± SEM,
n = 7; Close to each bar graph: representative histograms. *P < 0.05 vs Mo-DC. iDC: immature DC; MoDC: mature DCs; glu: D-
glucose; Man: D-mannitol.
6 diabetes research and clinical practice 170 (2020) 108528
Fig. 4 – Adiponectin (A) and Fetuin-A (B) levels in controls and enrolled patients. (C) Spearman rank correlation between
fetuin-A and adiponectin in all population (r = 0.492p value = 0.00108, (C) and in population stratified according to the
presence/absence of T2DM ± obesity (D). Adiponectin (E) and Fetuin-A (F) correlation with BMI in T2DM ± obese patients.
Spearman’s rank correlation coefficient r = 0.416p value = 0.0199 for adiponectin and r = 0.549 with p value = 0.00139 for
fetuin-A.
diabetes research and clinical practice 170 (2020) 108528 7
atherosclerosis has been under investigation. DCs at vascular circulating precursors, CD14+, during all their culture condi-
levels are reported to contribute to vascular remodeling, and tions (7 days). Nevertheless, when iDC were obtained in nor-
among them conventional DCs (cDCs) seem to have a pivotal moglycemic condition and then were let to maturate in the
role, although plasmacytoid DCs (pDCs) can be found in presence of high D-glucose for 24 h, Mo-DCs yield was not
atherosclerotic lesions in apolipoprotein E–deficient (Apoe / ) impaired. This result is apparently in contrast to that of Lu
and low-density lipoprotein receptor-deficient (Ldlr / ) mice et al (2013) [33], who reported an increase of DC yield in
[19,20]. In human tissue, cDCs, corresponding to the two sub- response to high D-glucose concentration. However, their
sets of myeloid DC as previously described [21], and CD123+ experimental design was different, since they applied high
pDC numbers were increased in unstable compared with D-glucose to CD14+ after a-5 days of normoglycemic condi-
stable lesions, mainly localizing to the shoulder region of pla- tion, without adding LPS for their maturation. More recently,
ques [22]. In patients with peripheral artery disease Kret- it was reported that hyperglycemic sera from T2DM patients
zschmar and co-authors (2015) [23] have reported a decrease impaired DC differentiation through ROS production [34],
in circulating DC precursors, suggesting an increase of their highlighting DC dysfunction in these patients which may be
accumulation into vessel lesions. Despite these data, it is responsible to their defective immune response.
unclear the pathogenetic role of DCs in the initiation of vas- Circulating fetuin-A and adiponectin were also measured
cular remodeling associated with high risk CVD. For this pur- in enrolled patients. Fetuin-A is an endogenous inhibitor of
pose, we selected post-menopausal obese woman with or insulin receptor and epidemiological and clinical studies
without diabetes or patients with diabetes alone without reported that high plasma fetuin-A levels are associated with
any previous major CV event, in order to characterize DC insulin resistance (IR), MetS and risk of T2DM [16,35], the lat-
function. We previously reported that Mo-DCs obtained from ter seemed more evident in women than in men [36]. In con-
T2DM obese post-menopausal woman display a defective trast adiponectin protects against insulin resistance/diabetes
phenotype compared to obese and control ones. Present and atherosclerosis and its plasma levels decrease in T2DM or
paper demonstrates the latter DC population being less able obese patients [37]. Our results show an inverse correlation
to stimulate CD8+ cytotoxic T lymphocytes, compared to between adiponectin and fetuin-A in enrolled patients, being
Mo-DCs obtained from obese or T2DM and control ones. fetuin-A significantly higher and adiponectin significantly
These data are a new observation and reflect the immune lower in T2DM obese patients compared to healthy subjects.
state of these patients, in which DC dysfunction may con- These results extend previous cross-sectional study in which
tribute to an increased susceptibility to infections and to fetuin-A and adiponectin were measured in a new diagnosed
higher risk of CVD [24,25]. It is known that obesity and T2DM patients (either male and female), younger than
T2DM diseases share T cell alterations that may contribute patients in our study and with a BMI > 25 [38]. Interestingly,
to their additional metabolic disturbances. In T2DM and obe- our present data showed that fetuin-A and adiponectin levels
sity there is a shift of CD4+T cell subsets toward a proinflam- were not significantly different in T2DM patients compared to
matory phenotype, such as CD4+ Th1 and Th17 and a controls. This result, apparently in contrast with previous
regulatory T cells (Treg) [26]. Proinflammatory Th1 cells pro- published, could be explained by pharmacological therapy.
ducing IFN-c are correlated with adiposity [27] and patients All T2DM enrolled woman were indeed treated with insulin
with diabetes display an increase of CD4+CD28null T lympho- sensitizers drugs, such as metformin or pioglitazone, which
cytes, a subpopulation exerting direct cytolytic and proapop- were reported to modulate adiponectin and/or fetuin in obese
totic effects on endothelial cells and vascular smooth muscle and/or T2DM patients [39–42], whose mechanisms, still under
cells [28,29]. investigation, are not likely dependent on improved glycemic
According to published data, our present paper strength- control alone.
ens metanflammation in enrolled population, since Mo-DCs
obtained from T2DM obese patients express higher mRNA 5. Conclusions
levels of integrins, such as CD18 and CD11c, compared to
obese or T2DM ones, which may modulate their adhesion to All together these data confirm a dysfunction of Mo-DCs
vascular wall cells, as previously published [14]. Among inte- obtained from circulating precursors of T2DM obese post-
grins binding vascular adhesion molecules, beta2 integrin menopausal woman without any clinical CV event docu-
CR4 (CD11c/CD18) seems to be important for a strong Mo- mented. The association of obesity with diabetes seems to
DC adhesion to fibrinogen in order to mediate their trans- worsen DC phenotype and function with potentially greater
endothelial migration [30]. Retention of leukocytes to vascular ability to mediate inflammation. Our data underline the
wall is involved in the worsening of inflammatory condition, importance of the multiple CV risk factors coexistence in a
leading to the progression and complication of vascular patient. Pharmacological treatment is almost certainly able
remodeling. Consistently, hyperglycaemia up-regulates adhe- to revert fetuin-A and adiponectin dysregulation in post-
sion molecule expression [31] modulating immune cells menopausal T2DM woman, while is not in T2DM obese ones.
recruitment, as reported in subcutaneous abdominal adipose
tissue of obese women without metabolic complications [32]. Fundings
Despite this, the effect of hyperglycaemia on DC phenotype
and function is still controversial. Present data show defective This work was supported by grants from University of Flor-
Mo-DCs yield when hyperglycaemia was applied to their ence (Research funding) to AP and CMR.
8 diabetes research and clinical practice 170 (2020) 108528
[31] Kostidou E, Koliakos G, Kaloyianni M. Increased monocyte Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K,
alphaL, alphaM and beta2 integrin subunits in diabetes Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S,
mellitus. Clin Biochem 2009;42(7-8):634–40. Hanafusa T, Matsuzawa Y. Plasma concentrations of a novel,
[32] Tencerová M, Kračmerova J, Krauzová E, Mališová L, adipose-specific protein, adiponectin, in type 2 diabetic
Kováčová Z, Wedellová Z, et al. Experimental hyperglycemia patients. Arterioscler Thromb Vasc Biol 2000;20(6):1595–9.
induces an increase of monocyte and T-lymphocyte content [38] Zhou Z-W, Ju H-X, Sun M-Z, Chen H-M, Fu Q-P, Jiang D-M.
in adipose tissue of healthy obese women. PLoS One 2015;10: Serum fetuin-A levels in obese and non-obese subjects with
e0122872. https://doi.org/10.1371/journal.pone.0122872. and without type 2 diabetes mellitus. Clin Chim Acta
[33] Lu H, Yao K, Huang D, Sun A, Zou Y, Qian J, Ge J. High glucose 2018;476:98–102.
induces upregulation of scavenger receptors and promotes [39] Mori K, Emoto M, Araki T, Yokoyama H, Lee E, Teramura M,
maturation of dendritic cells. Cardiovasc Diabetol 2013;12 Koyama H, Shoji T, Inaba M, Nishizawa Y. Effects of
(1):80. https://doi.org/10.1186/1475-2840-12-80. pioglitazone on serum fetuin-A levels in patients with type 2
[34] Gilardini Montani MS, Granato M, Cuomo L, Valia S, Di Renzo diabetes mellitus. Metabolism 2008;57(9):1248–52.
L, D’Orazi G, Faggioni A, Cirone M. High glucose and [40] Wang H, Ni Y, Yang S, Li H, Li Xu, Feng Bo. The effects of
hyperglycemic sera from type 2 diabetic patients impair DC gliclazide, metformin, and acarbose on body composition in
differentiation by inducing ROS and activating Wnt/b-catenin patients with newly diagnosed type 2 diabetes mellitus. Curr
and p38 MAPK. Biochimica et Biophysica Acta (BBA) – Mole Therapeutic Res 2013;75:88–92.
Basis Disease 2016;1862(4):805–13. [41] Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA,
[35] Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, Koyama Sinha M, Olefsky JM. The effect of thiazolidinediones on
H, Shoji T, Inaba M, Nishizawa Y. Association of serum fetuin- plasma adiponectin levels in normal, obese, and type 2
A with insulin resistance in type 2 diabetic and nondiabetic diabetic subjects. Diabetes 2002;51(10):2968–74.
subjects. Diab Care 2006;29(2). [42] Ochi A, Mori K, Emoto M, Nakatani S, Morioka T, Motoyama
[36] Guo VY, Cao B, Cai C, Cheng K-Y, Cheung BMY. Fetuin-A levels K, et al. Direct inhibitory effects of pioglitazone on hepatic
and risk of type 2 diabetes mellitus: a systematic review and fetuin-A expression. PLoS One 2014;9:1–8. https://doi.org/
meta-analysis. Acta Diabetol 2018;55(1):87–98. 10.1371/journal.pone.0088704.
[37] Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M,
Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K,